Nasdaq · CIK 0001541119
SFBC Sound Financial Bancorp, Inc.
Insider trading from SEC Form 4. Last filing 13 d ago. Close $42.46 on Oct 9, 2026, +4% from the 52-week low and -13% from the high.
Last 90 days
Net insider value
-$41k
more sold than bought
Buys
0
$0 by 0 insiders
Sells
1
$41k by 1 insider
Insiders on file
7
with a Form 4 at this company
Price and insider trades, last year
SFBCOct 9, 2026 · close 42.46
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Sound Financial Bancorp, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 16Weak | Laura Lee Stewart Chief Executive Officer sell | $41k 900 shares | -10% | +10% from low-9% from high | |
| 11Weak | Laura Lee Stewart President and CEO sell | $40k 900 shares | -8% | +6% from low-14% from high | |
| 23Weak | David S Haddad Jr director sell | $19k 356 shares | -9% | - | |
| 23Weak | David S Haddad Jr director sell | $2,204 41 shares | -1% | - | |
| 34Weak | James E Sweeney director sell | $44k 831 shares | -22% | - | |
| 23Weak | David S Haddad Jr director sell | $162 3 shares | -0% | - | |
| 43Moderate | James E Sweeney director sell | $106k 1,969 shares | -34% | - |
Transactions
The last 31 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | Laura Lee Stewart Chief Executive Officer | SOpen-market sale Common Stockindirect: By CRT10b5-1 | -900 | $45.99 | $41k | 8,100 | 13 d ago |
| Mar 31, 2026 | Laura Lee Stewart President and CEO | SOpen-market sale Common Stockindirect: By CRT10b5-1 | -900 | $44.13 | $40k | 9,900 | Mar 31, 2026 |
| Aug 16, 2024 | Laura Lee Stewart President and CEO | GGift Common Stock | -3,000 | $0.00 | $0 | 60,402 | Jan 23, 2026 |
| Nov 13, 2025 | Heidi Sexton Executive Vice President/COO | MOption exercise Common Stock | +2,500 | $28.34 | $71k | 17,657 | Jan 23, 2026 |
| Nov 13, 2025 | Heidi Sexton Executive Vice President/COO | FTax withholding Common Stock | -1,584 | $44.74 | $71k | 16,073 | Jan 23, 2026 |
| Nov 13, 2025 | Heidi Sexton Executive Vice President/COO | MOption exercise Stock Option (Right to Buy)derivative | -2,500 | $0.00 | $0 | 0 | Jan 23, 2026 |
| Dec 10, 2025 | Debra Jones director | GGift Common Stock | -500 | $0.00 | $0 | 20,995 | Dec 11, 2025 |
| Dec 4, 2025 | Wes Ochs President and CFO | MOption exercise Common Stock | +900 | $28.34 | $26k | 7,245 | Dec 5, 2025 |
| Dec 4, 2025 | Wes Ochs President and CFO | FTax withholding Common Stock | -577 | $44.23 | $26k | 6,668 | Dec 5, 2025 |
| Dec 4, 2025 | Wes Ochs President and CFO | MOption exercise Stock Option (Right to Buy)derivative | -900 | $0.00 | $0 | 300 | Dec 5, 2025 |
| Nov 13, 2025 | Heidi Sexton Executive Vice President/COO | MOption exercise Common Stock | +2,500 | $28.34 | $71k | 17,657 | Nov 14, 2025 |
| Nov 13, 2025 | Heidi Sexton Executive Vice President/COO | FTax withholding Common Stock | -1,584 | $44.74 | $71k | 16,073 | Nov 14, 2025 |
| Nov 13, 2025 | Heidi Sexton Executive Vice President/COO | MOption exercise Stock Option (Right to Buy)derivative | -2,500 | $0.00 | $0 | 0 | Nov 14, 2025 |
| Aug 6, 2025 | David S Haddad Jr director | GGift Common Stock | -22 | $0.00 | $0 | 4,368 | Aug 6, 2025 |
| Jun 9, 2025 | Debra Jones director | GGift Common Stock | -3,785 | $0.00 | $0 | 21,495 | Jun 9, 2025 |
| Jan 6, 2025 | Robert F Carney director | MOption exercise Common Stock | +300 | $18.36 | $5,508 | 7,796 | Jan 7, 2025 |
| Jan 6, 2025 | Robert F Carney director | MOption exercise Stock Option (Right to Buy)derivative | -300 | $0.00 | $0 | 0 | Jan 7, 2025 |
| Jan 3, 2025 | David S Haddad Jr director | MOption exercise Common Stock | +862 | $18.36 | $16k | 4,390 | Jan 6, 2025 |
| Jan 3, 2025 | David S Haddad Jr director | MOption exercise Stock Option (Right to Buy)derivative | -862 | $0.00 | $0 | 0 | Jan 6, 2025 |
| Dec 17, 2024 | Robert F Carney director | MOption exercise Common Stock | +562 | $18.36 | $10k | 7,496 | Dec 19, 2024 |
| Dec 17, 2024 | Robert F Carney director | MOption exercise Stock Option (Right to Buy)derivative | -562 | $0.00 | $0 | 300 | Dec 19, 2024 |
| Nov 12, 2024 | David S Haddad Jr director | SOpen-market sale Common Stock | -356 | $53.78 | $19k | 3,528 | Nov 13, 2024 |
| Nov 8, 2024 | Debra Jones director | MOption exercise Common Stock | +250 | $33.50 | $8,375 | 25,280 | Nov 12, 2024 |
| Nov 7, 2024 | James E Sweeney director | SOpen-market sale Common Stockindirect: By 401(k) | -239 | $52.42 | $13k | 3,534 | Nov 12, 2024 |
| Nov 8, 2024 | David S Haddad Jr director | SOpen-market sale Common Stock | -41 | $53.75 | $2,204 | 3,884 | Nov 12, 2024 |
| Nov 8, 2024 | Debra Jones director | MOption exercise Stock Option (Right to Buy)derivative | -250 | $0.00 | $0 | 0 | Nov 12, 2024 |
| Nov 8, 2024 | James E Sweeney director | SOpen-market sale Common Stockindirect: By 401(k) | -592 | $52.57 | $31k | 2,942 | Nov 12, 2024 |
| Nov 5, 2024 | David S Haddad Jr director | SOpen-market sale Common Stock | -3 | $54.04 | $162 | 3,925 | Nov 7, 2024 |
| Nov 4, 2024 | James E Sweeney director | SOpen-market sale Common Stockindirect: By 401(k) | -1,358 | $53.76 | $73k | 4,384 | Nov 6, 2024 |
| Nov 5, 2024 | James E Sweeney director | SOpen-market sale Common Stockindirect: By 401(k) | -78 | $53.58 | $4,179 | 4,306 | Nov 6, 2024 |
| Nov 6, 2024 | James E Sweeney director | SOpen-market sale Common Stockindirect: By 401(k) | -533 | $53.25 | $28k | 3,773 | Nov 6, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Robert F Carneydirector
- David S Haddad Jrdirector
- Debra Jonesdirector
- Wes OchsPresident and CFO
- Heidi SextonExecutive Vice President/COO
- Laura Lee StewartPresident and CEO
- James E Sweeneydirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.